• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊收缩素-B 受体在肿瘤性胃细胞中的表达。

Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.

机构信息

Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

Department of Pathology, St Olav's Hospital-Trondheim University Hospital, Trondheim, Norway.

出版信息

Horm Cancer. 2018 Feb;9(1):40-54. doi: 10.1007/s12672-017-0311-8. Epub 2017 Oct 4.

DOI:10.1007/s12672-017-0311-8
PMID:28980157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5775387/
Abstract

Gastric cancer is an important disease due to its high mortality. Despite the decline in frequency, most cases are discovered late in its course, and most of the cancer patients die within a few years of diagnosis. In addition to Helicobacter pylori gastritis, gastrin is considered an important factor in the development of this disease, and thus, cholecystokinin-B receptor (CCKBR) becomes of interest. The aim of our study was to explore whether CCKBR is expressed in stomach cancers. Thirty-seven tumors from 19 men and 18 women diagnosed with either adenocarcinoma or neuroendocrine neoplasm (NENs) were included in this study. The tumors were classified into 29 adenocarcinomas and eight NENs. Immunohistochemistry with antibodies against chromogranin A (CgA), synaptophysin and CCKBR, and in situ hybridization with probes against CgA, CCKBR and histidine decarboxylase were used to further explore these tumors. Thirty-three (89%) of the tumors expressed CCKBR protein, whereas only 20 (54%) of all tumors expressed CCKBR mRNA. Of the 20 tumors expressing CCKBR mRNA, eight were NENs and 12 were adenocarcinoma. The highest amount of CCKBR was expressed in NEN. Interestingly, a high degree of co-expression of CCKBR and CgA was observed when the two markers were examined together with in situ hybridization. In conclusion, we found that all eight NENs expressed CCKBR and neuroendocrine markers in a majority of tumor cells. The same markers were also expressed in a proportion of adenocarcinomas supporting the view that gastrin is important in the development of gastric cancer.

摘要

胃癌是一种重要的疾病,因为其死亡率很高。尽管发病率有所下降,但大多数病例在病程晚期才被发现,大多数癌症患者在诊断后几年内死亡。除了幽门螺杆菌胃炎外,胃泌素被认为是这种疾病发展的一个重要因素,因此,胆囊收缩素 B 受体(CCKBR)成为研究的焦点。我们的研究目的是探讨 CCKBR 是否在胃癌中表达。本研究纳入了 19 名男性和 18 名女性的 37 例肿瘤,这些患者被诊断为腺癌或神经内分泌肿瘤(NEN)。这些肿瘤分为 29 例腺癌和 8 例 NEN。使用针对嗜铬粒蛋白 A(CgA)、突触素和 CCKBR 的抗体进行免疫组织化学染色,以及针对 CgA、CCKBR 和组氨酸脱羧酶的探针进行原位杂交,以进一步探索这些肿瘤。33 例(89%)肿瘤表达 CCKBR 蛋白,而所有肿瘤中只有 20 例(54%)表达 CCKBR mRNA。在表达 CCKBR mRNA 的 20 例肿瘤中,有 8 例为 NEN,12 例为腺癌。NEN 表达的 CCKBR 最多。有趣的是,当同时使用原位杂交检查这两种标志物时,观察到 CCKBR 和 CgA 的高度共表达。总之,我们发现所有 8 例 NEN 均表达 CCKBR 和神经内分泌标志物,大多数肿瘤细胞均表达这些标志物。同样的标志物也在一部分腺癌中表达,这支持胃泌素在胃癌发展中很重要的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/b70f4bcfee34/12672_2017_311_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/b7e9ed7f6129/12672_2017_311_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/4d40bf08c253/12672_2017_311_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/4cbcb1398c26/12672_2017_311_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/5ad2a39f8181/12672_2017_311_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/b70f4bcfee34/12672_2017_311_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/b7e9ed7f6129/12672_2017_311_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/4d40bf08c253/12672_2017_311_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/4cbcb1398c26/12672_2017_311_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/5ad2a39f8181/12672_2017_311_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f97/10355868/b70f4bcfee34/12672_2017_311_Fig5_HTML.jpg

相似文献

1
Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.胆囊收缩素-B 受体在肿瘤性胃细胞中的表达。
Horm Cancer. 2018 Feb;9(1):40-54. doi: 10.1007/s12672-017-0311-8. Epub 2017 Oct 4.
2
Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.胆囊收缩素和胃泌素受体在胃癌和胰腺癌中的异质性表达:一项免疫组织化学研究。
J Cancer Res Ther. 2016 Jan-Mar;12(1):411-6. doi: 10.4103/0973-1482.168970.
3
Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.曲妥珠单抗通过胃泌素启动的CCKBR信号传导抑制HER2阴性胃癌细胞的生长。
Dig Dis Sci. 2015 Dec;60(12):3631-41. doi: 10.1007/s10620-015-3793-7. Epub 2015 Jul 15.
4
Gastrin activates autophagy and increases migration and survival of gastric adenocarcinoma cells.胃泌素激活自噬并增加胃腺癌细胞的迁移和存活率。
BMC Cancer. 2017 Jan 21;17(1):68. doi: 10.1186/s12885-017-3055-5.
5
Characterization of gastrins and their receptor in solid human gastric adenocarcinomas.人胃腺癌中胃泌素及其受体的特征分析
Scand J Gastroenterol. 2013 Jun;48(6):688-95. doi: 10.3109/00365521.2013.783101. Epub 2013 Apr 2.
6
Low serum gastrin associated with ER breast cancer development via inactivation of CCKBR/ERK/P65 signaling.低血清胃泌素通过 CCKBR/ERK/P65 信号通路失活与 ER 阳性乳腺癌的发生相关。
BMC Cancer. 2018 Aug 16;18(1):824. doi: 10.1186/s12885-018-4717-7.
7
Gastrokine 1 inhibits gastrin-induced cell proliferation.胃动素1抑制胃泌素诱导的细胞增殖。
Gastric Cancer. 2016 Apr;19(2):381-391. doi: 10.1007/s10120-015-0483-2. Epub 2015 Mar 10.
8
Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.胆囊收缩素2受体(CCK2R)在胃肠道间质瘤发病机制中的促进作用。
J Pathol. 2012 Dec;228(4):565-74. doi: 10.1002/path.4071. Epub 2012 Sep 28.
9
Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.胃泌素诱导的miR-222通过抑制p27kip1促进胃肿瘤发展。
Oncotarget. 2016 Jul 19;7(29):45462-45478. doi: 10.18632/oncotarget.9990.
10
Deletion of and induces hypergastrinemia and gastric carcinoids.和的缺失会诱发高胃泌素血症和胃类癌。
Gut. 2017 Jun;66(6):1012-1021. doi: 10.1136/gutjnl-2015-310928. Epub 2016 Feb 9.

引用本文的文献

1
The need for a better classification system for gastric neoplasms.对更好的胃肿瘤分类系统的需求。
Nat Rev Dis Primers. 2025 Jan 23;11(1):6. doi: 10.1038/s41572-024-00590-2.
2
Identification of gastric cancer biomarkers through analysis of microarray based datasets.通过基于微阵列数据集的分析来鉴定胃癌生物标志物。
Biochem Biophys Rep. 2024 Nov 24;40:101880. doi: 10.1016/j.bbrep.2024.101880. eCollection 2024 Dec.
3
Gene Expression Analysis before and after the Pelvic Flexure in the Epithelium of the Equine Hindgut.马后肠上皮中骨盆弯曲前后的基因表达分析

本文引用的文献

1
Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma.
APMIS. 2017 Mar;125(3):213-222. doi: 10.1111/apm.12654.
2
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.奈扎替丁,一种胃泌素/胆囊收缩素-2受体拮抗剂,可根除自身免疫性慢性萎缩性胃炎患者的胃神经内分泌肿瘤。
Br J Clin Pharmacol. 2017 Mar;83(3):466-475. doi: 10.1111/bcp.13146. Epub 2016 Nov 21.
3
The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment.胃泌素受体拮抗剂奈扎替丁(YF476)用于1型胃肠嗜铬样细胞神经内分泌肿瘤患者:长期治疗综述
Animals (Basel). 2024 Aug 8;14(16):2303. doi: 10.3390/ani14162303.
4
Correctly identifying the cells of origin is essential for tailoring treatment and understanding the emergence of cancer stem cells and late metastases.正确识别肿瘤起源细胞对于制定个性化治疗方案以及理解癌症干细胞的产生和晚期转移至关重要。
Front Oncol. 2024 Apr 10;14:1369907. doi: 10.3389/fonc.2024.1369907. eCollection 2024.
5
Elevated Serum Gastrin Is Associated with Melanoma Progression: Putative Role in Increased Migration and Invasion of Melanoma Cells.血清胃泌素水平升高与黑色素瘤进展相关:可能在黑色素瘤细胞迁移和侵袭增加中发挥作用。
Int J Mol Sci. 2023 Nov 28;24(23):16851. doi: 10.3390/ijms242316851.
6
The central role of gastrin in gastric cancer.胃泌素在胃癌中的核心作用。
Front Oncol. 2023 Oct 24;13:1176673. doi: 10.3389/fonc.2023.1176673. eCollection 2023.
7
Inflammation and Digestive Cancer.炎症与消化道癌症
Int J Mol Sci. 2023 Aug 31;24(17):13503. doi: 10.3390/ijms241713503.
8
Gastrin: From Physiology to Gastrointestinal Malignancies.胃泌素:从生理学到胃肠道恶性肿瘤。
Function (Oxf). 2021 Nov 26;3(1):zqab062. doi: 10.1093/function/zqab062. eCollection 2022.
9
Gastrin/CCK-B Receptor Signaling Promotes Cell Invasion and Metastasis by Upregulating MMP-2 and VEGF Expression in Gastric Cancer.胃泌素/缩胆囊素B受体信号通过上调胃癌中MMP-2和VEGF的表达促进细胞侵袭和转移。
J Cancer. 2022 Jan 1;13(1):134-145. doi: 10.7150/jca.51854. eCollection 2022.
10
Time to Classify Tumours of the Stomach and the Kidneys According to Cell of Origin.根据细胞起源对胃和肾脏肿瘤进行分类。
Int J Mol Sci. 2021 Dec 13;22(24):13386. doi: 10.3390/ijms222413386.
Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1345-1352. doi: 10.1097/MEG.0000000000000713.
4
Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival.高胃泌素血症与胃体腺癌及患者较短生存期相关。
APMIS. 2015 Jun;123(6):509-14. doi: 10.1111/apm.12380. Epub 2015 May 5.
5
A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen?影响福尔马林固定石蜡包埋(FFPE)组织分子、蛋白质和形态学分析的分析前因素综述:你对自己的FFPE标本了解多少?
Arch Pathol Lab Med. 2014 Nov;138(11):1520-30. doi: 10.5858/arpa.2013-0691-RA.
6
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
7
Cell lineage distribution atlas of the human stomach reveals heterogeneous gland populations in the gastric antrum.人类胃细胞谱系分布图揭示了胃窦中不同的腺体群体。
Gut. 2014 Nov;63(11):1711-20. doi: 10.1136/gutjnl-2013-305964. Epub 2014 Jan 31.
8
Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.奈妥匹肽,一种胃泌素受体拮抗剂,在一项针对慢性萎缩性胃炎患者的非随机试验中,可使肿瘤标志物正常化,并使 1 型胃神经内分泌肿瘤消退。
PLoS One. 2013 Oct 1;8(10):e76462. doi: 10.1371/journal.pone.0076462. eCollection 2013.
9
Characterization of gastrins and their receptor in solid human gastric adenocarcinomas.人胃腺癌中胃泌素及其受体的特征分析
Scand J Gastroenterol. 2013 Jun;48(6):688-95. doi: 10.3109/00365521.2013.783101. Epub 2013 Apr 2.
10
Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.胃泌素受体拮抗剂奈妥匹肽(YF476)治疗胃类癌 1 型可使肿瘤消退,并使血清嗜铬粒蛋白 A 恢复正常。
Aliment Pharmacol Ther. 2012 Dec;36(11-12):1067-75. doi: 10.1111/apt.12090. Epub 2012 Oct 16.